STOCK TITAN

The Joint (JYNT) Stock Price, News & Analysis

JYNT NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
10 252 sessions, November 17, 2025 to November 17, 2026
Largest daily move
+7.9% close of June 11, 2026
1-year change
-19% closing prices, November 17, 2025 to November 17, 2026
1-month change
-5.4% closing prices, October 16, 2026 to November 17, 2026

Company Description

The Joint Corp. (NASDAQ: JYNT) is a national operator, manager and franchisor of chiropractic clinics that conduct business under The Joint Chiropractic® brand. According to company disclosures, The Joint Corp. introduced a retail healthcare business model for chiropractic care in 2010 and has since grown into what it describes as the nation’s largest operator, manager and franchisor of chiropractic clinics. The company is headquartered in Scottsdale and reports a footprint of over 950 locations nationwide and more than 14 million patient visits annually through The Joint Chiropractic network.

The Joint Corp. is classified in the Real Estate and Rental and Leasing sector under “Lessors of Nonfinancial Intangible Assets (except Copyrighted Works),” reflecting its focus on franchising and intellectual property licensing. The company develops, owns, operates, supports and manages chiropractic clinics through a mix of direct ownership, management arrangements and franchising. It also sells regional developer rights in certain territories. The company has disclosed that it operates with one primary operating business segment, Franchise Operations, which derives revenue by providing access to the company’s franchise license and related symbolic intellectual property.

Retail healthcare and chiropractic focus

The Joint Chiropractic brand is positioned around convenient, consumer-facing access to chiropractic care. Company materials emphasize a retail setting and what they describe as concierge-style services. For patients, this model is characterized by no appointments, no insurance hassles, affordable chiropractic care and extended hours of operation, including evenings and weekends. The company states that millions of Americans have sought pain relief and ongoing wellness through its clinics, highlighting chiropractic care as a natural, drug-free approach to healthcare.

The clinics are staffed by Doctors of Chiropractic, who develop personalized treatment plans to relieve patients’ pain and deliver ongoing preventative care. The company notes that regular chiropractic adjustments can realign the spine and reduce nerve interference, which it associates with benefits such as improved mobility and resilience to physical and mental stress. The Joint Corp. presents its offering as suitable for a broad range of patients seeking pain relief and wellness-focused care.

Franchise-driven, asset-light model

The Joint Corp. emphasizes an asset-light franchise model as a core element of its strategy. The company describes itself as a franchisor of clinics and an operator of clinics in certain states. In multiple states, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices, reflecting a structure tailored to state-level healthcare and professional practice regulations. The company has also disclosed that it is refranchising company-owned or managed clinics and has entered into asset purchase agreements to sell corporate clinics to existing franchisees and operators.

Recent company communications describe a multi-year strategy to strengthen its core operations, reignite growth and improve both clinic-level and company-level profitability. As part of this strategy, The Joint Corp. has reported refranchising dozens of clinics and increasing the proportion of franchised locations in its portfolio. It has also entered into agreements to sell groups of corporate clinics in regions such as Arizona, New Mexico and the Southeast to franchise operators, while acquiring or adjusting regional developer rights in certain territories.

Regional developer rights and development structure

The Joint Corp. uses regional developer arrangements in parts of its system. The company has reported acquiring regional developer rights to the Northwest Region, covering existing franchised clinics and sites for future development in regions of Northern California, Utah, Nevada, Washington and Oregon. It has also disclosed transactions in which it sells assets of company-owned or managed clinics and grants franchise rights to buyers, sometimes in combination with development rights for additional clinics in designated metropolitan statistical areas.

These arrangements reflect a model in which the company’s intellectual property and franchise system are central assets. Franchisees and regional developers gain access to The Joint Chiropractic brand, systems and support under license and development agreements, while the company seeks to expand its footprint and royalty base through franchised and managed clinics.

Brand recognition and franchise positioning

The Joint Chiropractic brand has been repeatedly highlighted in franchise and business rankings. Company press releases state that the brand is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” list of 40 fastest-growing brands. Entrepreneur magazine has named The Joint “No. 1 in Chiropractic Services” and has regularly ranked the brand on its “Franchise 500,” “Fastest-Growing Franchises,” “Best of the Best,” “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners” lists. SUCCESS magazine has recognized the company as one of the “Top 50 Franchises.”

In Franchise Times’ Top 400 ranking, The Joint Chiropractic has been reported as climbing within the top 200, with a position of 139 in one recent listing, which the company cites as validation of its brand strength and model. The company also notes that it participates in two of the fastest-growing sectors in that ranking: health and medical, and personal services.

Patient experience and marketing

The Joint Corp. has highlighted a focus on patient experience, marketing and digital capabilities. The company has reported initiatives to enhance its brand campaign, pivoting messaging from broad-based wellness to a sharper emphasis on pain relief. It has discussed shifting portions of advertising spend to national media and investing in marketing infrastructure, including search engine optimization and AI-search, to improve clinic microsite performance and drive website rankings.

The company has also launched a mobile app, which it describes as a tool to enrich the patient experience and extend patient lifetime value. Leadership updates have included appointments of executives with experience in franchise operations, brand building and digital marketing, reflecting an emphasis on franchisee relations, operational excellence and brand development.

Business structure and regulatory considerations

The Joint Corp. discloses that it is both a franchisor and an operator of clinics in certain states. In various states, including Arkansas, California, Colorado, the District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, West Virginia and other listed jurisdictions, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices. This structure is designed to comply with state-level requirements around professional practice ownership while allowing The Joint Chiropractic brand and systems to be implemented across a wide footprint.

The company’s SEC filings also describe its use of a revolving credit facility with a major financial institution, and amendments to that credit agreement that, among other things, provide lender consent to refranchising efforts and extend the maturity date of the revolving credit line. The company has also disclosed a stock repurchase program, with board authorization for additional repurchase capacity over time.

Strategic refranchising and portfolio evolution

In recent disclosures, The Joint Corp. has detailed multiple asset purchase agreements and completed transactions involving the sale of company-owned or managed clinics to franchisees and franchise groups. Examples include the sale of clinics in Arizona and New Mexico to a large franchisee, the sale of clinics in Kansas and Missouri to a regional buyer, and an agreement (later terminated) to sell clinics in Southern California to a franchise group. The company has also announced an asset purchase agreement to sell 22 corporate clinics in the Southeast to existing members of its franchise community.

These transactions are presented by the company as part of a broader refranchising strategy aimed at increasing the share of franchised clinics in the system and moving toward what it describes as a pure play franchisor model. The company links these efforts to goals of strengthening its core business, improving clinic economics and enhancing overall profitability.

Recognition within chiropractic and franchising

The Joint Corp. describes The Joint Chiropractic as a key leader in the chiropractic industry, based on its national scale, patient visit volume and recognition in franchise rankings. The brand’s positioning at the intersection of healthcare and retail is emphasized in company materials, which describe The Joint Chiropractic as “where healthcare meets retail.” This reflects the company’s focus on consumer-friendly access, retail locations and standardized service offerings under a franchise system.

Stock Performance

$6.65
-0.15%
-0.01
Last updated: November 17, 2026 at 16:00
-19%
Performance 1 year
$91.0M

The Joint (JYNT) closed at $6.65 on November 17, 2026. Over the past 12 months, the price has lost 19.0%.

See what a $1,000 investment in JYNT would be worth today

Average down calculator for JYNT

JYNT Metrics & Rankings

Price returns through November 17, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Insider Radar

Net Buyers
90-Day Summary
5,829
Shares Bought
0
Shares Sold
3
Transactions
Most Recent Transaction
JOBSON CHARLES E (10% Owner) bought 2,825 shares @ $6.65 on November 10, 2026

Insider buying activity at The Joint over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

The Joint generated $54.9M in revenue in FY2025, retaining a 79.5% gross margin, operating income reached -$913K (-1.7% operating margin), and net income was $2.9M, reflecting a 5.3% net profit margin. Diluted earnings per share stood at $0.19. The company generated $1.8M in operating cash flow. The current ratio was 1.59, measuring current assets divided by current liabilities.

$54.9M
Revenue (FY2025)
$2.9M
Net Income (FY2025)
$1.8M
Operating Cash Flow

Upcoming Events

DEC
31
December 31, 2026 Financial

Fiscal 2026 year-end

Fiscal year-end for 2026 (2026-12-31). Company updated 2026 system-wide sales guidance to $508M–$512M.

The Joint has 1 upcoming scheduled event. The next event, "Fiscal 2026 year-end", is scheduled for December 31, 2026 (in 44 days). It is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the JYNT stock price.

Short Interest History

Last 12 Months

Short interest in The Joint (JYNT) currently stands at 323.5 thousand shares, down 7.4% from the previous reporting period, representing 2.9% of the float. Since November 2025, short interest has decreased by 53.5%.

Days to Cover History

Last 12 Months

Days to cover for The Joint (JYNT) currently stands at 7.4 days, up 81.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 64.7%. Across the settlements charted above, it has ranged from 2.0 to 31.2 days.

JYNT Company Profile & Sector Positioning

The Joint (JYNT) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing JYNT often look at related companies in the same sector, including WW International, Inc. (WW), Park Dental Partners, Inc. (PARK), AirSculpt Technologies, Inc. (AIRS), Cryo-Cell International Inc. (CCEL), and Community Health Systems, Inc. (CYH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate JYNT's relative position within its industry.

Frequently Asked Questions

The current stock price of The Joint (JYNT) is $6.65 as of November 17, 2026.

The market cap of The Joint (JYNT) is approximately $91.0M. Learn more about what market capitalization means .

The FY2025 revenue of The Joint (JYNT) is $54.9M, from its most recent completed fiscal year.

The FY2025 net income of The Joint (JYNT) is $2.9M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of The Joint (JYNT) is $0.19 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of The Joint (JYNT) is $1.8M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of The Joint (JYNT) is 5.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of The Joint (JYNT) is -1.7% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of The Joint (JYNT) is 79.5% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of The Joint (JYNT), current assets divided by current liabilities, was 1.59 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of The Joint (JYNT) is $43.7M for FY2025, its most recent completed fiscal year.

The operating income of The Joint (JYNT) is -$913K for FY2025, its most recent completed fiscal year. Learn about operating income.

The Joint Corp. (NASDAQ: JYNT) is a national operator, manager and franchisor of chiropractic clinics that conduct business under The Joint Chiropractic brand. It develops, owns, operates, supports and manages clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights in the United States.

The Joint Corp. reports one primary operating segment, Franchise Operations, which derives revenue by providing customers access to the company’s franchise license and related symbolic intellectual property. The company also participates in transactions involving the sale of corporate clinics and regional developer rights, and it operates and manages certain clinics directly or through management arrangements.

Company materials describe The Joint Chiropractic as a retail healthcare business model that emphasizes convenience and accessibility. Features highlighted include a retail setting, no appointments, no insurance hassles, affordable chiropractic care and extended hours of operation, including evenings and weekends, all aimed at making chiropractic services easier to access for patients seeking pain relief and wellness.

According to company press releases, The Joint Chiropractic network consists of over 950 locations nationwide and delivers more than 14 million patient visits annually. These figures are used by the company to illustrate the scale of its operations and its role in the chiropractic industry.

The Joint Corp. is classified in the Real Estate and Rental and Leasing sector, within the industry category “Lessors of Nonfinancial Intangible Assets (except Copyrighted Works).” This reflects its role as a franchisor and licensor of intellectual property associated with The Joint Chiropractic brand and system.

The Joint Corp. states that it is a franchisor of clinics and an operator of clinics in certain states. In various states, including Arkansas, California, Colorado, the District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington and West Virginia, the company and its franchisees provide management services to affiliated professional chiropractic practices, reflecting state-specific practice structures.

The company reports that The Joint Chiropractic is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” lists. Entrepreneur has named the brand “No. 1 in Chiropractic Services” and regularly includes it on the “Franchise 500,” “Fastest-Growing Franchises,” “Best of the Best,” “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners” lists. SUCCESS has named the company one of the “Top 50 Franchises.”

In its public communications, The Joint Corp. describes a multi-year strategy to strengthen its core operations, reignite growth and improve profitability at both the clinic and company levels. Key elements include refranchising company-owned or managed clinics, adjusting regional developer arrangements, investing in marketing and digital capabilities such as search engine optimization and a mobile app, and focusing brand messaging on pain relief.

The Joint Corp. has disclosed that it uses regional developer arrangements in certain territories. For example, it acquired regional developer rights to the Northwest Region, which includes existing franchised clinics and sites for future clinic development in regions of Northern California, Utah, Nevada, Washington and Oregon. These rights are part of its approach to supporting and expanding its franchised clinic network.

The company states that Doctors of Chiropractic in The Joint Chiropractic clinics develop personalized treatment plans to relieve patients’ pain and deliver ongoing preventative care. Chiropractic adjustments are described as a way to realign the spine and reduce nerve interference, which the company associates with benefits such as improved mobility and resilience to physical and mental stress.